Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water [Seeking Alpha]
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: Seeking Alpha
LFCR is a business with real competitive advantages that is executing at a very high level, where the stock has solid downside protection, and earnings power is growing. LFCR is well on their way to $100M in EBITDA versus a current enterprise value of approximately $400M where a 16x multiple would be conservative here. Lifecore Biomedical experienced fantastic execution toward increasing capacity utilization, and it seems as if the necessary elements of earnings power improvement and a re-rating are already in place. VectorFusionArt/iStock via Getty Images The following segment was excerpted from the Laughing Water Capital Q4 2025 Letter I have written about this investment extensively in the past, but in brief, Lifecore Biomedical ( LFCR ), our CDMO that puts injectable This article was written by Quick Insights Recent wins with large multinationals, each expected to be top 5 customers, should allow LFCR to significantly exceed prior new business and capacity utiliza
Show less
Read more
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- Lifecore Biomedical (NASDAQ:LFCR) was upgraded by analysts at Zacks Research to a "hold" rating.MarketBeat
- Lifecore Biomedical: The Turnaround Is Just Getting Started [Seeking Alpha]Seeking Alpha
- Wall Street Week Ahead [Seeking Alpha]Seeking Alpha
- HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- One Lifecore Biomedical Insider Raised Their Stake In The Previous Year [Yahoo! Finance]Yahoo! Finance